Source comparison
PT-141 Be Cycled Like Other Research Compounds: Comparison Table
Growth Hormone Secretagogues GHRP-2, MK-677 GHRH receptor agonism → pituitary GH release 4–8 weeks daily dosing, 2–4 week washout to prevent pituitary desensitisation Not applicable. Melanocortin receptors desensitise within 48–72 hours, not 4 weeks; washout n
This comparison does not assign a generated winner or score.
- Growth Hormone Secretagogues
- GHRP-2, MK-677
- GHRH receptor agonism → pituitary GH release
- 4–8 weeks daily dosing, 2–4 week washout to prevent pituitary desensitisation
- Not applicable. Melanocortin receptors desensitise within 48–72 hours, not 4 weeks; washout needs are 72–96 hours, not 2–4 weeks
- GH peptide cycling exists to preserve pituitary function; PT-141 acts on neural circuits with fundamentally different desensitisation kinetics
- GLP-1 Receptor Agonists
- Semaglutide, Tirzepatide
- GLP-1R agonism → insulin secretion, gastric emptying delay
- Continuous weekly dosing without cycling (half-life supports steady-state maintenance)
- Not applicable. GLP-1 agonists don’t require cycling because receptor desensitisation is minimal and therapeutic effect depends on sustained plasma levels
- PT-141 has a 2.7-hour half-life vs 5–7 days for GLP-1 agonists; the pharmacokinetic profiles are incompatible
- Melanocortin Receptor Agonists
- PT-141, Melanotan II
- MC3R/MC4R agonism → neural circuit modulation
- Interval dosing: 2–3x weekly with 48+ hour gaps; optional 4–6 week observation phase every 12–16 weeks
- Fully applicable. This IS the melanocortin protocol; PT-141 be cycled like other research compounds in this class specifically
- Melanocortan agonists share desensitisation timelines; interval dosing preserves receptor sensitivity across extended study periods
- Collagen Synthesis Peptides
- BPC-157, TB-500
- Tissue repair signalling, angiogenesis promotion
- 4–6 weeks continuous daily dosing, 2–4 week washout (though evidence for cycling necessity is weak)
- Not applicable. These peptides don’t act on G-protein-coupled receptors with rapid desensitisation; their effects are cumulative tissue-level changes
- Collagen peptide cycling is largely traditional rather than mechanistically necessary; PT-141’s receptor dynamics are unrelated